Programme
09:15 - 09:30
Registration
16:00 - 18:30
Champalimaud Auditorium
09:15 - 09:30
Welcome Reception
17:00 - 18:30
Amphitheater
Complex Pancreatic Cancer Surgery
Cancer Systems and spatial approaches
Coffee Break
World Pancreas Forum (WPF)*
Vision of Champalimaud Foundation
Clinical applications for molecular subtypes
Complication Management in Pancreatic Surgery
Lunch
09:15 - 09:30
Welcome Introduction
08:30 - 09:00
Champalimaud Auditorium
- João Silveira Botelho, Vice-President of the Champalimaud Foundation, Lisbon, Portugal
- Peter Bailey, Director of Translational Research of the Botton-Champalimaud Pancreatic Cancer Centre, Lisbon, Portugal
- Markus Büchler, Director of the Botton-Champalimaud Pancreatic Cancer Centre, Lisbon, Portugal
09:15 - 09:30
Targeting RAS
09:00 – 11:00
Champalimaud Auditorium
Chairs:
- Andreas Trumpp, Heidelberg, Germany
- Faiyaz Notta, Toronto, Canada
- Laura Wood, Baltimore, USA
- Scott Lowe
09:00 - 09:20
Targeting KRAS-driven Pancreatic Cancer
Mariano Barbacid, Madrid, Spain
09:20 - 09:40
The effects of pan-RAS inhibition on models of pancreatic ductal adenocarcinoma
Kenneth Olive, Boston, USA
10:00 - 10:20
KRAS inhibitors: resistance mechanisms and combinations
Channing Der, North Carolina, USA
10:20 - 10:40
Targeting RAS in Pancreatic Cancer
Andrew Aguirre, Boston, USA
09:15 - 09:30
Radiology / Diagnostics / Artificial Intelligence for PDAC
09:00 – 11:00
Botton Auditorium
Chairs:
- Celso Matos, Lisbon, Portugal
- Christoph Springfeld, Heidelberg, Germany
- Kuirong Jiang, Nanjing, China
- Martin Loos, Heidelberg, Germany
09:00 - 09:20
Evidence-based Radiology
Carlos Bilreiro, Lisbon, Portugal
09:20 - 09:40
Radiology of the Pancreas: State of the Art
Gõtz Richter, Stuttgart, Germany
09:40 - 10:00
Artificial Intelligence for Diagnosis
Dow Mu Koh, London, UK
10:00 - 10:20
Artificial Intelligence for Screening
TBC
10:20 - 10:40
Interventional Radiology: Collections
Hugo Rio-Tinto, Lisbon, Portugal
10:40 - 11:00
Interventional Radiology: Bleeding
De-Hua Chang, Luzern, Switzerland
09:15 - 09:30
Coffee Break
10:40 - 11:30
09:15 - 09:30
Invasion and Metastasis
11:30 - 13:10
Champalimaud Auditorium
Chairs:
- Anirban Maitra, New York, USA
- David Ting, Boston, USA
- Kenneth Olive, Boston, USA
- William Hwang, Boston, USA
11:30 - 11:50
Exploring metabolic pathways that promote metastatic pancreatic cancer
Sophie Vasseur, Marseille, France
11:50 - 12:10
Insights into liver versuslung metastatic tropism in pancreatic ductal adenocarcinoma
Rosalie Sears, Portland, USA
12:10 - 12:30
Molecular and functional analysis of PDAC innervating neurons
Andreas Trumpp, Heidelberg, Germany
12:30 - 12:50
Lineage restricted evolutionary patterns in PDAC
Giannicola Genovese, Houston, USA
12:50 - 13:10
Tumor-Nerve Interactions in Pancreatic Cancer
William Hwang, Boston, USA
09:15 - 09:30
Surgery vs wait and see: PanNET and other rare malignancies
11:30 - 13:30
Botton Auditorium
Chairs:
- Keith Lillemoe, Boston, USA
- Nuh Rahbari, Ulm, Germany
- Ugo Boggi, Pisa, Italy
- Volkan Adsay, Istanbul, Turkey
11:30 - 11:50
Is every PanNET malignant?
Pelin Bağci, Lisbon, Portugal
11:50 - 12:10
Radiology of PanNETs
Mark Anderson, Boston, USA
12:10 - 12:30
PanNET: Surgical Experience with 800 Patients
Thomas Hank, Heidelberg, Germany
12:30 - 12:50
PanNET Debate: Watch and Wait
Alessandro Zerbi, Milan, Italy
12:50 - 13:10
PanNET Debate: Surgery
Marta Sousa, Lisbon, Portugal
13:10 - 13:30
Rare Pancreatic Neoplasms
Christoph Berchtold, Heidelberg, Germany
09:15 - 09:30
Nanjing Campus 2025 - the new projects*
11:30 - 13:00
Seminar Room
Chairs:
- Yi Miao, Nanjing, China
- Kuirong Jiang, Nanjing, China
Mentors:
- Christoph Wolfgang, New York, USA
- Giovanni Marchegiani, Padova, Italy
- Jens Werner, Munich, Germany
- Jin He, Baltimore, USA
- Zipeng Lu, Nanjing, China
11:30 - 11:40
Prognostic Factors Based on Tumor Location (Head vs. Body/Tail) in the Era of Neoadjuvant Chemotherapy
Thomas Hank, Heidelberg, Germany
11:40 - 11:50
Postoperative Adjuvant Therapy and Optimization of Treatment Strategies in Pancreatic Cancer Patients Following Neoadjuvant Therapy
Yazhou Wang, Nanjing, China
11:50 - 12:00
Quality of Life Outcomes Following Conversion Therapy in BRPC and LAPC – Is It Worth It?
Saneya Pandrowala, Mumbai, India
12:00 - 12:10
Short- and Long-Term Outcomes of Minimally Invasive vs. Open Duodenum-Preserving Pancreatic Head Resection for Chronic Pancreatitis
Kongyuan Wei, Xi’an, China
12:10 - 12:20
Definition, Prediction, and Treatment of Post-Pancreatectomy Liver Injury
Nicola Canitano, Padova, Italy
12:20 - 12:30
Comparative Analysis of Post-Pancreatic Surgical Complications in Elderly vs. Younger Patients with Small Inactive Neuroendocrine Pancreatic Tumors
Ughur Aghamaliyev, Munich, Germany
12:30 - 12:40
Synthetic Allograft vs. Autologous Left Renal Vein for Venous Interposition – Proposal for a Randomized Controlled Multicenter Clinical Trial
Benedict Kinny-Koster, Heidelberg, Germany
12:40 - 12:50
Multicentric RCT on the Use of Anticoagulation After Venous Resection
Filipe Borges, Lisbon, Portugal
09:15 - 09:30
Lunch
13:30 - 14:20
09:15 - 09:30
Principles of Pancreatic Cancer Surgery
14:00 - 16:00
Champalimaud Auditorium
Chairs:
- Christopher Wolfgang, New York, USA
- Cristina Ferrone
- Helmut Friess
- Yi Miao, Nanjing, China
14:00 - 14:20
Surgery of peri-ampullary cancer
Richard Schulick, Denver, USA
14:20 - 14:40
Standards of oncological pancreatic head resection
Pierluigi Di Sebastiano, Pescara, Italy
14:40 - 15:00
Pancreatic Anastomosis
Waldemar Uhl, Bochum, Germany
15:00 - 15:20
Left Resection: RAMPS
Guralp Ceyhan, Istanbul, Turkey
15:20 - 15:40
Artery-first approaches
Kuirong Jiang, Nanjing, China
15:40 - 16:00
Total pancreatectomy
Miguel Fróis Borges, Lisbon, Portugal
09:15 - 09:30
PDAC Tumour microenvironment (1)
14:20 - 16:00
Botton Auditorium
Chairs:
- Andrew Aguirre, Boston, USA
- Claus Jørgensen, Manchester, UK
- Giannicola Genovese, Houston, USA
- Mariano Barbacid, Madrid, Spain
14:20 - 14:40
Spatial proteomic maps of pancreatic cancer extend tumour subtype and microenvironment classifications
Hartland Jackson, Toronto, Canada
14:40 - 15:00
The Viral Basis of Pancreatic Cancer
David Ting, Boston, USA
15:00 - 15:20
Extracting mechanisms of cell cross talk in pancreatic cancer using big data
Nina Steele, Cincinnati, USA
15:20 - 15:40
Decoding the plasticity of stroma during pancreatic cancer progression and chemoresistance
Corinne Bousquet, Toulouse, France
15:40 - 16:00
Detecting and Preventing Lethal Pancreatic Cancer
Anirban Maitra, New York, USA
09:15 - 09:30
Coffee Break
16:00 - 16:30
09:15 - 09:30
Surgery for Borderline / LA PDAC
16:30 - 18:30
Champalimaud Auditorium
Chairs:
- Pauli Puolakkainen, Helsinki, Finland
- Phillipe Bachellier
- Richard Schulik, Colorado, USA
- Waldemar Uhl, Bochum, Germany
16:30 - 16:50
Multivisceral Resection
Helmut Friess, Munich, Germany
16:50 - 17:10
Triangle Operation
Vera Oliveira, Lisbon, Portugal
17:10 - 17:30
Peri-Arterial Divestment
Yi Miao, Nanjing, China
17:30 - 17:50
DP-CARs (Appleby) Operation
Filipe Borges, Lisbon, Portugal
17:50 - 18:10
Venous Resection
Martin Schneider, Giessen, Germany
18:10 - 18:30
Arterial Resection
Markus Büchler, Lisbon, Portugal
09:15 - 09:30
Early detection, liquid biopsies and treatment for pancreatic cancer
16:30 - 18:30
Botton Auditorium
Chairs:
- Carlos Carvalho
- Dirk Jäger
- Grainne O’Kane, Dublin, Ireland
- Jin He, Baltimore, USA
16:30 - 16:50
The Liver - Pancreatic Cancer Interaction
Heiner Wedemeyer, Hannover, Germany
16:50 - 17:10
Plasma whole genomes in pancreatic cancer
Faiyaz Notta, Toronto, Canada
17:10 - 17:30
PRECEDE Consortium
Dianne Simeone, California, USA
17:30 - 17:50
CT Imaging Meets AI: A Fusion Deep-Learning Model Accurately Predicts Metastasis in Pancreatic Cancer Patients
Núria Malats, Madrid, Spain
17:50 - 18:10
PANcreatic Cancer Initial Detection via liquid biopsy
Matthias Löhr, Stockholm, Sweden
18:10 - 18:30
Revolutionised pancreatic cancer treatment
Beat Müller, Basel, Switzerland
09:15 - 09:30
Advanced Model Systems
09:00 – 11:00
Champalimaud Auditorium
Chairs:
- Channing Der, North Carolina, USA
- Giulia Biffi, Cambridge, UK
- Marina Pasca di Magliano, Michigan, USA
- William Hwang, Boston, USA
09:00 - 09:20
Understanding and exploiting barriers to pancreatic tumorigenesis
Scott Lowe, New York, USA
09:20 - 09:40
Defining and characterising the functional microenvironment of Pancreatic Cancer
Claus Jørgensen, Manchester, UK
09:40 - 10:00
Closing the circle: ex vivo and in vivo engineering of focal gene amplifications
Andrea Ventura, New York, USA
10:00 - 10:20
Spatial perturbation screens uncover immune-evasive tumor niches in pancreatic cancer
Chiara Falcomatà, New York, USA
10:20 – 10:40
Deep learning and integration of multi-omics for better understanding the early evolution of pancreatic cancer
Ashley Kiemen, Baltimore, USA
09:15 - 09:30
Session: IPMN
09:00 – 11:00
Botton Auditorium
Chairs:
- Andre Mihaljevic
- Felix Nickel, Hamburg, Germany
- Yuichi Nagakawa, Tokyo, Japan
- Zipeng Lu, Nanjing, China
09:00 - 09:20
Pathology of IPMN
Volkan Adsay, Istanbul, Turkey
09:20 - 09:40
Genomic landscape
Anguraj Sadanandam, Lisbon, Portugal
09:40 - 10:00
EUS in IPMN
Andrew Metz, Melbourne, Australia
10:00 - 10:20
Principles of surgery for IPMN
Cristina Ferrone, Los Angeles, USA
10:20 - 10:40
Debate: Watch and Wait
Stefano Crippa, Milan, Italy
10:40 - 11:00
Debate: surgery
Ana João, Lisbon, Portugal
09:15 - 09:30
ISGPS session*
09:00 – 11:00
Seminar Room
09:15 - 09:30
Coffee Break
10:40 - 11:30
09:15 - 09:30
Robotic Pancreatic Surgery (1)
11:10 – 13:10
Champalimaud Auditorium
Chairs:
- Emanuel Vigia
- Kevin Conlon
- Michael Ghadimi, Berlin, Germany
- Safi Dokmak
11:10 - 11:30
Evidence based robotic surgery
Marc Besselink, Amsterdam, Netherlands
11:30 - 11:50
Pioneering robotic pancreatic surgery
Herbert Zeh, Texas, USA
11:50 - 12:10
Robotic Surgery: Selection is Key
Nuh Rahbari, Ulm, Germany
12:10 - 12:30
Minimally Invasive Pancreatic Surgery
Ugo Boggi, Pisa, Italy
12:30 - 12:50
Robotic Pancreatic Head Resection
Felix Nickel, Hamburg, Germany
12:50 - 13:10
Organ Preserving Surgery
Jin He, Baltimore, USA
09:15 - 09:30
Advances in Pancreatic Cancer Oncology (1)
11:30 – 13:30
Botton Auditorium
Chairs:
- Götz Richter, Stuttgart, Germany
- Kim Reiss, Philadelphia, USA
- Paulo Costa
- Rong Liu
11:30 - 11:50
Neoadjuvant treatment
Carlos Carvalho, Lisbon, Portugal
11:50 - 12:10
Adjuvant treatment
John Neoptolemos, Heidelberg, Germany
12:10 - 12:30
Immunotherapy
Elke Jäger, Frankfurt, Germany
12:30 - 12:50
Systemic treatment opportunities and challenges
Philip Philip, Detroit, USA
12:50 - 13:10
GemPred trials: predicting Gemcitabine sensitivity
Jérôme Cros, Paris, France
13:10 - 13:30
Update on PASS-1 trial: signature stratifications for treatment
Grainne O’Kane, Dublin, Ireland
09:15 - 09:30
Lunch
12:30 - 14:00
09:15 - 09:30
Robotic Pancreatic Surgery (2)
14:00 – 16:00
Champalimaud Auditorium
Chairs:
- Herbert Zeh
- Jürgen Weitz, Germany
- Mark Besselink
- Oliver Strobel
14:00 - 14:20
Robotic surgery: the learning curve
Amer Zureikat, Pittsburgh, USA
14:20 - 14:40
Techniques for anastomosis in robotic pancreatic surgery
Jiahong Dong, Beijing, China
14:40 - 15:00
Robotic Left Resection
Gil Gonçalves, Lisbon, Portugal
15:00 - 15:20
Robotic Triangle Operation
Yuichi Nagakawa, Tokyo, Japan
15:20 - 15:40
Complications after robotic pancreatic surgery
Rong Liu, Beijing, China
09:15 - 09:30
Advances in Pancreatic Cancer Oncology (2)
14:00 – 16:00
Botton Auditorium
Chairs:
- Ashok Saluja
- Elke Jäger
- John Neoptolemos, Heidelberg, Germany
- Philip Philip, Detroit, USA
14:00 - 14:20
Developing a clinically viable MYC inhibitor: to boldly go where no one has gone before
Laura Soucek, Barcelona, Spain
14:20 - 14:40
PARP inhibitors and other maintenance therapies
Kim Reiss, Philadelphia, USA
14:40 - 15:00
Vaccination strategies
Dirk Jäger, Heidelberg, Germany
15:00 - 15:20
Cell-based therapies for pancreatic cancer
Christoph Springfeld, Heidelberg, Germany
15:20 - 15:40
Targeting IL1beta in combination with chemotherapy in advanced and localized pancreatic cancer
Paul Oberstein, New York, USA
15:40 - 16:00
Therapeutic Strategies Targeting the TME in PDAC
Manuel Hidalgo, New York, USA
09:15 - 09:30
Coffee break
16:00 - 16:30
09:15 - 09:30
Surgery of Advanced Pancreatic Cancer
16:30 – 18:30
Champalimaud Auditorium
Chairs:
- Amer Zureikat
- Beat Müller
- Markus Diener, Nürnberg, Germany
- Pierluigi Di Sebastiano, Chieti, Italy
16:30 - 16:50
Resect the unresectable
Jürgen Weitz, Dresden, Germany
16:50 - 17:10
Arterial Reconstruction
Christopher Wolfgang, New York, USA
17:10 - 17:30
Multivascular Resection
Philippe Bachellier, Strasbourg, France
17:30 - 17:50
Portal vein occlusion: is reconstruction always necessary?
Jens Werner, Munich, Germany
17:50 - 18:10
Venous reconstruction techniques
Giovanni Marchegiani, Padova, Italy
18:10 - 18:30
Portal vein arterialization
Arianeb Mehrabi, Heidelberg, Germany
09:15 - 09:30
PDAC Tumour microenvironment (2)
16:30 - 18:10
Botton Auditorium
Chairs:
- Corinne Bousquet, Toulouse, France
- Hartland Jackson, Toronto, Canada
- Nina Steele, Cincinnati, USA
- Sophie Vasseur, Marseille, France
16:30 - 16:50
Establishment and temporal evolution of the pancreatic cancer microenvironment
Marina Pasca di Magliano, Michigan, USA
16:50 - 17:10
TBC
Direna Alonso-Curbelo, Barcelona, Spain
17:10 - 17:30
Roles of fibroblasts in pancreatic cancer metastasis and cachexia
Giulia Biffi, Cambridge, UK
17:30 - 17:50
Rag GTPase signaling in myeloid cells links nutrient overload with inflammation and PDAC
Alejo Efeyan, Madrid, Spain
17:50 - 18:10
Epigenetic reprogramming of pancreatic cancer to leverage anti-PD1 immunotherapy
Silvestre Vicent, Pamplona, Spain
09:15 - 09:30
APP (Associação Portuguesa do Pâncreas) Session*
16:30 - 17:00
Seminar Room

09:15 - 09:30
ESPAC session*
16:30 - 18:30
Seminar Room
Chairs:
- John Neoptolemos, Heidelberg, Germany
- Maximilian Reichert, Munich, Germany
- Markus Büchler, Lisbon, Portugal
16:30 - 16:40
ESPAC6 and 7 - Overview
Thomas Hank, Heidelberg, Germany
16:40 - 16:50
ESPAC6 - Update
Sabine Beck, Frankfurt, Germany
16:50 - 17:00
State of the Art - treatment of Pancreatic Cancer
Christoph Springfeld, Heidelberg, Germany
17:00 - 17:10
The ESPAC signature - quality control
Benedikt Brors, Heidelberg, Germany
17:10 - 17:20
Sample logistics
Tessa Peccerella, Heidelberg, Germany
17:20 - 17:30
The ESPAC translational programme - overview
Maximilian Reichert, Munich, Germany
17:30 - 17:40
The ESPAC translational programme - Role of the tumor microenvironment
Barbara Grünwald, Essen, Germany
17:40 - 17:50
The ESPAC Translational Programme - De-centralized Organoid Workflow and Co-culture Models
Daniel Öhlund, Umea, Sweden
17:50 - 18:00
ESPAC7 - Surgical Decision Making
Güntaç Uzunoğlu, Hamburg, Germany
18:00 - 18:30
Discussion
Welcome / Introduction
Advances in Pancreatic Cancer Treatment
Coffee Break
Advances in Pancreatic Cancer Treatment (Cont.)
Lunch Break
Cell plasticity and tumor heterogeneity
Developing Standards
International Study Group of Pancreatic Surgery (ISGPS)*
Coffee Break
Surgery vs wait and see: PanNET’s and IPMN
Surgery for Locally Advanced PDAC
09:15 - 09:30
Surgery of Oligometastatic Pancreatic Cancer
09:00 – 11:00
Champalimaud Auditorium
Chairs:
- Alessandro Zerbi, Milan, Italy
- Gil Gonçalves, Lisbon, Portugal
- Jiahong Dong, Beijing China
- Martin Schneider, Giessen, Germany
09:00 - 09:20
Indications for surgery
Markus Diener, Nürnberg, Germany
09:20 - 09:40
Standards of surgical treatment
Oliver Strobel, Vienna, Austria
09:40 - 10:00
Liver after lung or both?
Pauli Puolakkainen, Helsinki, Finland
10:00 - 10:20
The German RCT
Michael Ghadimi, Gottingen, Germany
10:20 - 10:40
Surgery of peritoneal disease
Mohammed Al-Saeedi, Heidelberg, Germany
10:40 - 11:00
TBC
09:15 - 09:30
Early Career Research Session
09:00 – 12:30
Botton Auditorium
Chairs:
- Alejo Efeyan, Madrid, Spain
- Andrea Ventura, New York, USA
- Ashley Kiemen, Baltimore, USA
- Chiara Falcomatà, New York, USA
- Direna Alonso-Curbelo, Madrid, Spain
- Rosalie Sears, Portland, USA
09:00 - 09:15
Würth sponsored talk
Aris Papargyriou
09:15 - 09:30
Würth sponsored talk - Global mapping of drug synergy landscapes through massively parallel Cas13d genetic interaction screening
Juan J. Montero, Munich, Germany
09:30 - 09:45
Würth sponsored talk - Targeting mutual dependence of PI3Kα/δ and SUMO signaling in pancreatic cancer
Matthias Wirth, Göttingen, Germany
09:45 - 10:00
Würth sponsored talk - Using pluripotent stem cell derived pancreatic organoids to model human pancreas organogenesis and disease
Jonathan Brassard, Cincinnati, USA
10:00 - 10:15
Würth sponsored talk - The RNA regulator HuR promotes pancreatic cancer liver metastasis through control of stress response pathways
Katherine Pelz, Oregon, USA
10:15 - 10:30
Würth sponsored talk - Uncovering Drug Resistance and Prognostic Biomarkers: Correlative Science Insights from the SPEAR and MoST-P Clinical Trials
Aparna Raina, Sydney, Australia
10:30 - 10:45
PCUK sponsored talk
TBC
10:45 - 11:00
PCUK sponsored talk
TBC
11:00 - 11:15
PCUK sponsored talk
TBC
11:15 - 11:30
PCUK sponsored talk
TBC
09:15 - 09:30
Breakout Session: Young Pancreatologists Forum*
09:00 – 11:00
Seminar Room
Chairs:
- Thomas Hank, Heidelberg, Germany
- Filipe Borges, Lisbon, Portugal
09:00 - 09:10
TBC
Minel Borges, Lisbon, Portugal
09:10 - 09:20
Pancreatic surgery in Kiev
Liudmilla Pererva, Kiev, Ukraine
09:20 - 09:30
TBC
Greg Sacks, New York, USA
09:30 - 09:40
Development and Validation of a Cell-Free DNA Fragmentomics–Based Model for Early Detection of Pancreatic Cancer
Lingdi Yin, Nanjing, China
09:40 - 09:50
TBC
Atsushi Oba, Tokyo, Japan
09:50 - 10:00
Pierluigi recommendation
TBC
10:00 - 10:10
TBC
Loiusa Bolm, Lubeck
10:10 - 10:20
TBC
Jon Harrison, Stanford / Boston, USA
10:20 - 10:30
TH recommendation
TBC
10:30 - 10:40
Andrew Metz’ recommendation
TBC
10:40 - 10:50
GM recommendation
TBC
10:50 - 11:00
TBC
09:15 - 09:30
Coffee Break
10:40 - 11:30
09:15 - 09:30
Surgery of Pancreatic Cancer
11:30 - 13:00
Botton Auditorium
Chairs:
- Arianeb Mehrabi, Heidelberg, Germany
- Luís Graça
- Mohammed Al-Saeedi, Heidelberg, Germany
- Robert Grützmann, Erlangen, Germany
11:30 - 11:50
Radicality of the triangle operation
Andre Mihajlevic, Tubingen, Germany
11:50 - 12:10
Portal Hypertension: bypass
Martin Loos, Heidelberg, Germany
12:10 - 12:30
Revolutionised pancreatic cancer treatment
Beat Müller, Basel, Switzerland
12:30 - 12:50
Drainage after pancreatic surgery
Kevin Conlon, Dublin, Ireland
12:50 - 13:10
TBC
09:15 - 09:30
Breakout Session: World Pancreas Forum - “The center effect”*
11:30 - 13:00
Seminar Room
Chairs:
- Ashok Saluja
- Christoph Wolfgang, New York, USA
- Markus Büchler, Lisbon, Portugal
- Yi Miao, Nanjing, China
11:30 - 11:40
The future of the WPF
Kasper Zgraggen, Bern, Switzerland
11:40 - 11:50
Caseload and experience
Jishu Wei, Nanjing, China
11:50 - 12:00
Clinical Trials
Benedict Kinny-Köster, New York, USA
12:10 - 12:20
The role of research to increase quality
Filipe Borges, Lisbon, Portugal
12:20 - 12:30
The learning curve
Adrian Billeter, Basel, Switzerland
12:30 - 12:40
Teaching the Junior Pancreatic Surgeon
Saneya Pandrowala, Mumbai, India
12:40 - 12:50
Better quality with bigger teams
Ingmar Rompen, New York, USA
09:15 - 09:30
Recurrence of Pancreatic Cancer
11:30 - 13:30
Champalimaud Auditorium
Chairs:
- Christoph Berchtold, Heidelberg, Germany
- Giovanni Marchegiani, Padova, Italy
- Jens Werner, Munich, Germany
- Jerome Cros, Paris, France
11:30 - 11:50
Radiology of Recurrence
Mark Wielpütz, Greifswald, Germany
11:50 - 12:10
Predictive Factors of Early Recurrence
Elsa Francisco, Lisbon, Portugal
12:10 - 12:30
How to Prevent
Zipeng Lu, Nanjing, China
12:30 - 12:50
Radiotherapy
Inês Antunes, Lisbon, Portugal
12:50 - 13:10
Surgical Treatment
Robert Grützmann, Erlangen, Germany
13:10 - 13:30
Multivisceral and Complex Surgery
Safi Dokmak, Paris, France